Skip to main content
. 2022 Jan 7;13(2):196–202. doi: 10.1021/acsmedchemlett.1c00555

Figure 5.

Figure 5

Target inhibition potency of 18k in EGFRC797S mutant BaF3 cells and PC9 cells. Cells were treated with indicated compounds for 2 h, and the activation of EGFR and downstream signaling molecule were evaluated using Western Blot analysis.